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Summary 
In this study we aimed to examine a role for interleukin  6  (IL-6) and its receptor (IL-6R) in 
peripheral nerve regeneration in vivo. We first observed that cultured mouse embryonic dorsal 
root ganglia exhibited dramatic neurite extension by simultaneous addition of IL-6 and soluble 
IL-6R (slL-6R), a complex that is known to interact with and activate a signal transducing re- 
ceptor component,  gp130.  After injury in the hypoglossal nerve in adult mice by ligation, im- 
munoreactivity  to IL-6 was upregulated  in Schwann  cells at the lesional site as well as in the 
cell bodies of hypoglossal neurons  in the brain stem.  In the latter,  upregnlation  of the immu- 
noreactivity  to  IL-6R was  also  observed.  Regeneration  of axotomized  hypoglossal  nerve  in 
vivo was significantly retarded by the administration  of anti-IL-6R antibody.  Surprisingly,  ac- 
celerated regeneration of the axotomized nerve was achieved in transgenic mice constitutively 
expressing both IL-6 and IL-6R, as compared with nontransgenic  controls.  These results sug- 
gest that the IL-6 signal may play an important role in nerve regeneration after trauma in vivo. 
I 
L-6 is expressed in a wide variety of cell lineages includ- 
.ing  monocytes/macrophages  (1),  T  cells  (2),  fibroblasts 
(3,  4),  and  endothelial  cells  (5,  6)  in  response  to  diverse 
stimuli.  It is also of interest to note the presence of IL-6 in 
the nervous system because this molecule is structurally ho- 
mologous to such neuro-acting  cytokines as ciliary neuro- 
trophic factor (CNTF) 1 and leukemia inhibitory factor (LIF) 
(7)  which share, in their receptor complexes, the  IL-6 sig- 
nal  transducer,  gp130  (8-19).  In  the  central  nervous  sys- 
tem, IL-6 expression was observed, for instance, in the py- 
ramidal neurons  of the  hippocampus  and  granular  cells  of 
the  cerebellum  (20).  Upregnlation  of IL-6  in  the  central 
nervous  system after viral  infection  and  mechanical  crush 
was reported  (21-23).  Although  it has been  observed that 
IL-6  acts  as  a  survival  factor for  nerve  cells  including  rat 
mesencephalic  and septal neurons  in vitro  (24,  25),  its role 
in  vivo  has  been  demonstrated  poorly.  Whereas  gpl30  is 
widely expressed, the spectrum of the targets of IL-6 in the 
nervous  system appears to be much narrower  than  that of 
LIF  and  CNTF  due  to  relatively  limited  expression  of 
1Abbreviations used in this paper: CNTF, ciliary neurotrophic factor; DRG, 
dorsal root ganglion; L1F, leukemia inhibitory factor; pAb, polyclonal an- 
tibody; slL-GR, soluble IL-GR; TG, transgenic. 
IL-6R in the nervous system. In this study, we focus on a 
role of IL-6 and IL-6R in peripheral nerve regeneration af- 
ter trauma. We first show that peripheral nerve cells, which 
normally are not responsive to IL-6, have a potential to re- 
spond to this factor when IL-6R is simultaneously present. 
We also show that both IL-6 and IL-6R proteins are upregu- 
lated  after  nerve  injury.  With  further  experiments  using 
blocking Ab to IL-6R and transgenic  (TG) mice expressing 
IL-6 and  IL-6R,  we  discuss  the  contribution  of IL-6  and 
IL-6R to nerve regeneration in vivo. 
Materials and Methods 
Culture of Dorsal Root Ganglia.  Dorsal root ganglia (DRGs) from 
17-d  ICR-embryos were  embedded  in  0.1%  collagen  (Koken, 
Tokyo, Japan)  in DME/Ham's12  (GIBCO BILL, Gaithersburg, 
MD), 10% FCS in multidishes  (Nunc Inc., Naperville,  IL) (1 DRG/ 
0.3  ml/well).  DME/Ham's12  with  10%  FCS  containing  either 
human IL-6 (2 p.g/ml), human soluble IL-6R (slL-6R; 1 Ixg/ml), 
IL-6 plus slL-6R (2 Ixg/ml and I Ixg/ml, respectively), or rat CNTF 
(2  Ixg/rnl)  was then  overlaid (0.9  ml/well).  DRGs were  incu- 
bated for 4 d and photographed (Nikon, Tokyo, Japan). 
Nerve Injury and lmmunostaining.  Under pentobarbital anesthe- 
sia, rrfice were positioned supine and right and let~ hypoglossal nerves 
were carefully exposed through a ventral neck incision and mobi- 
lized at a site proximal from the bifurcation of the nerve near the 
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string. 1 wk after operation, the mice were anesthetized and per- 
fused through the heart with 500 ml heparinized phosphate buffer 
(0.1 M, pH 7.4),  followed by 750 ml of 4% paraformaldehyde in 
phosphate buffer.  The  ligated and  contra-lateral sham-operated 
nerves and brain stem were removed and postfixed overnight with 
2% paraformaldehyde and 0.2% picric acid in 0.2 M phosphate buf- 
fer  (pH 7.4);  they were then partially dehydrated overnight with 
30% sucrose. Frozen sections (7 I~m) were placed on gelatin-coated 
glass slides, dried, and rehydrated for 5 rain with 0.1 M  phosphate 
buffer, pH 7.0, containing 1% Triton >2-100.  The sections were 
then blocked for 3 h  with 0.1  M  PBS  containing 0.3% Triton 
X-100,  1% bovine serum albumin, and  1% normal goat serum 
(blocking buffer).  The  sections were  incubated with polyclonal 
rabbit Ab to mouse IL-6 or mouse IL-6R (5 ~g/ml; kindly pro- 
vided by Drs. Y. Koishihara and Y. Ohsugi, Chugai Pharmaceuti- 
cal, Gotemba, Japan) in the blocking buffer overnight, and washed 
three  times.  The  immunoreactivity was  detected with  affinity- 
purified biotinylated anti-rabbit Ig and Vectastain  TM  ABC Re- 
agent  (overnight incubations; Vector Laboratories, Inc., Burlin- 
game, CA) according to the manufacturer's procedures. 
Assay  for Nerve Regeneration.  Right and leti hypoglossal nerves 
were carefully exposed as described above. The nerve was tran- 
sected with a pair of scissors. The transected nerve was laid in a 
normal position, and the opening at the ventral neck was stitched. 
About 1 ILl of Fluorogold (Fluorochrome Inc., Englewood, CO) 
was  injected into both sides  of the tongue  in a careful bilateral 
manner on the day of each assay. 2 d later, mice were killed and 
the brains were frozen in crushed dry ice. Fresh frozen sections 
were made, the tracer dye was visualized by fluorescence micros- 
copy,  (Nikon) and the number of Fluorogold-stained nerve cell 
bodies were counted. Regeneration rate was assessed by calculat- 
ing the percent ratio of the number of stained cell bodies on the 
operated side of the brain stem to that in the sham-operated side. 
Treatment with Anti-IL-6R Ab.  Right and left hypoglossal nerves 
in  the  same  animal were  exposed as  described above,  and  the 
nerve on one side was transected. Either anti-IL-6R mAb (26) or 
control IgG was intraperitoneally injected weekly five times. Re- 
generation rate was assessed using Fluorogold as described above. 
TG Mice.  Two TG lines expressing either human IL-6 or hu- 
man IL-6R were separately prepared as reported previously (27). 
These two lines were mated to obtain double-TG mice express- 
ing both human  IL-6 and  IL-6R proteins.  The  offspring were 
classified  into  four  types  by  transmitted  genes:  6+6R+TG, 
6+6R-TG, 6-6R+TG, and 6-6R-TG, where 6 + and 6R + rep- 
resent the presence oflL-6 and IL-6R transgenes, respectively. In 
this study, we operated on 3-mo-old mice weighing ~  g. 
Results 
Neurite  Extension from  DRG  Cells Induced by  IL-6 Plus 
slL-6R.  A  neurotrophic  role  of IL-6  signaling was  first 
examined in cultured DRG  from mouse  embryos.  In this 
experiment  we  used  IL-6  and  slL-6R,  a  combination  of 
which  is  known  to  interact  with  and  activate  gp130,  as 
does the complex of IL-6 and membrane-anchored IL-6R 
(11). As shown in Fig. 1, simultaneous addition of IL-6 and 
slL-6R induced  significant neurite  extension from DRG. 
This combination was  as  (Fig.  1 E)  or even slightly more 
potent as CNTF.  Neither IL-6 nor slL-6R alone had any 
effect,  presumably because  DRG  cells express  gp130  but 
not IL-6 or IL-6R. In fact, immunoreactivity to gp130 but 
not  IL-6R  was  detectable  in  mouse  embryonic  DRG 
(Kiyama, H., K. Yoshida, and T.  Taga,  unpublished data). 
Neurite extension in this experiment was detectable on day 
1 and most obvious on days 3  and 4.  The result suggested 
that peripheral nerve cells have the potential to respond to 
the  IL-6 signal to  extend neurites,  and  implied that  those 
cells might exhibit such response in vivo when IL-6 is pro- 
duced  locally and  when  the  cells  are  induced  to  express 
IL-6R. This made us examine whether IL-6 and IL-6R are 
induced after nerve injury and are involved in nerve regen- 
eration in vivo.  In this line of study, we chose the mouse 
hypoglossal nerve  for its  ease  of manipulation  and  its ad- 
vantageous nature, that is, that each of the cell bodies local- 
ized in the brain stem extends the axon unilaterally towards 
the same side of the tongue. 
IL-6 Expression in the Injured Hypoglossal Nerve.  Both  sides 
of the hypoglossal nerves were carefully exposed through a 
ventral neck incision, and orlly one of the two was ligated 
with  strings  (see Materials and  Methods).  1  wk  after sur- 
gery, the ligated and contra-lateral sham-operated nerves, as 
well as brain stem,  were immunostained  with rabbit anti- 
mouse IL-6 polyclonal antibody (pAb) or rabbit anti-mouse 
IL-6R pAb. As shown in Fig. 2, Schwann cells in the oper- 
ated hypoglossal nerve at the position 500  ~m distal from 
the ligated site showed strongly enhanced staining for IL-6, 
as  compared with  the  sham-operated  nerve.  The  immu- 
noreactivity to IL-6R was, unanticipatedly, only marginally 
upregulated in the ligated nerve (data not shown), probably 
because the level of IL-6R protein in the axon of the hy- 
poglossal nerve was below the detection limit (with the use 
of this pAb). 
Immunolocalization  of IL-6 and  IL-6R  in  the  Hypoglossal 
Nuclei in the Brain Stem.  We then performed immunohis- 
tochemical staining of the nerve cell bodies in the brain stem. 
As  shown  in  Fig.  3,  immunoreactive  signals to  IL-6 and 
IL-6R were  both  upregulated in  the  operated side of the 
medulla  at  the  hypoglossal nucleus.  A  receptor-mediated 
mechanism of binding, uptake, and retrograde transport of 
neurotrophic  factors  such  as  nerve  growth  factor  (NGF) 
and  LIF  have  been  demonstrated  (28,  29).  These  factors 
bind to their receptors on the axon surface and the factor- 
receptor  complexes  are  suggested  to  be  internalized into 
endocytic vesicles, leaving the intracellular domains of the 
transmembrane receptors free to interact with cytoplasmic 
signaling molecules.  This  topology is  considered to  allow 
the  activated receptor  to  form  complexes  with  signaling 
molecules in  the  course  of retrograde  transport,  either in 
the axon or in the cell body. Such a consideration raises the 
possibility that, via a similar mechanism,  IL-6 protein pro- 
duced  at  the  lesion site binds  to  IL-6R  expressed  on  the 
axon surface,  the  IL-6/IL-6R complex is then  transferred 
to, and accumulated in, the cell bodies of neurons, allowing 
these proteins to be detectable in the brain stem by immu- 
nostaining.  It was  postulated that  a  relatevly low level of 
IL-6R expression led to the low intensity oflL-6 staining in 
the cell body. These results suggested that IL-6 is produced 
after nerve injury in Schwann cells and used by the surviv- 
ing nerve  cell bodies through  the remaining axons,  via the 
2628  Nerve Regeneration by the IL-6 Signal In Vivo Figure 1.  Neurite extension from DRG cells induced by IL-6 plus slL- 
6R.  Phase contrast photomontages illustrate the typical pattern of 17-d 
embryonic mouse DRG explants cultured for 4 d in the presence of me- 
dium (A), human IL-6 (B), human slL-6R (C-),  IL-6 and slL-6R (D), and 
CNTF (E). 
upregulated IL-6R protein, most likely to support regener- 
ation of axons. 
Retardation  of Regeneration  of the  Transected Hypoglossal 
Nerve by Administration of  Anti-IL-6R Ab in vivo.  To  ascer- 
tain whether the  injury-induced upregulation of IL-6 and 
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IL-6R is involved in nerve regeneration in vivo, anti-mouse 
IL-6R mAb which blocks IL-6 binding to the receptor was 
administrated after axotomy  (see Materials and  Methods). 
In  normal  IgG-treated mice,  the  number  of Fluorogold- 
positive cell bodies in the operated side of the hypoglossal Figure  2.  Upregulation of IL-6 expression in the injured hypoglossal nerve.  (A) Anti-IL-6 staining of the nerve 1 wk after ligadon injury at position 
500 p~m distal from the ligation site. (13) Sham-operated nerve at position equivalent to that in A. 
Figure 3.  Immunolocalization of IL-6 
and  IL-6R  in the hypoglossal nuclei in 
the brain stem. (A) Anti-IL-6R staining. 
(B) Anti-IL-6 staining. (Right) Operated 
side; (left) sham-operated side. 
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Figure  4.  Retardation of regenera- 
tion of the transected hypoglossal  nerve 
by anti-IL-6R  Ab.  Hypoglossal nerves 
were transected and the operated mice 
(n =  3) were intraperitoneally adminis- 
trated with control rat IgG (stippled  col- 
umn) or rat anti-mouse IL-6R blocking 
Ab (filled column) five times with  1-wk 
intervals (starting on the seventh day af- 
ter  operation).  The  regeneration rate 
was calculated as described in the text. 
Vertical bars, SD. 
nucleus  was  23.0  +  0.90%  of that  in  the  sham-operated 
side.  In contrast, in the anti-IL-6R mAb-treated mice,  the 
number  of Fluorogold-positive  cells  in  the  operated  side 
was only  14.8  +  0.76%  of that in the  sham-operated side 
(Fig.  4).  The  results  indicated  that  the  administration  of 
anti-IL-6R blocking mAb reduced the regeneration of the 
nerve by 36% when assayed 5  wk after surgery.  This  sug- 
gests that the IL-6 signal is required  to a substantial  extent 
for peripheral nerve regeneration. 
Accelerated  Nerve  Regeneration  in  TG  Mice  Constitutively 
Expressing both IL-6 and IL-6R.  We then examined whether 
the rate of nerve regeneration is affected in TG mice over- 
expressing  human  IL-6 and/or  human  IL-6R.  In the  re- 
generation assay described above,  Fluorogold-positive cells 
in the operated side of the hypoglossal nucleus in the brain 
stem  4  wk  after  axotomy were  not  so  prominent  in  the 
non-TG control (see Fig.  5 A  for a representative  section: 
the number of tracer positive cells  was 14.2  +- 2.1% of that 
in the sham-operated side  [the average of the  results  from 
three  mice]).  In contrast,  6+6R+TG  mice showed appar- 
ently  more  improved  regeneration:  the  number  of Fluo- 
rogold-positive  cells  in  the  operated  side  was  40  +  3.0% 
(the  average of the  results  from three  mice)  of that in the 
sham-operated side  (i.e.,  a 2.8-fold increase from the con- 
trol; see Fig. 5  B for a representative section). At this stage, 
nerve regeneration in mice carrying either of the transgenes 
(6+6R-TG  and  6-6R*TG)  was  comparable  with  that  in 
6-6R-TG  mice.  The  kinetics  of nerve  regeneration  was 
measured in the  TG mice of the four different genotypes. 
As shown in Fig. 6, the 6+6R+TG mice achieved nerve re- 
generation  1.5-2.0  wk  faster  than  the  other  TG  mice. 
These results  support  the idea that  IL-6 signaling contrib- 
utes to nerve regeneration. 
Discussion 
Administration oFCNTF, a member of the IL-6 family of 
cytokines, is known to:  (a) prevent degeneration of axoto- 
mized facial  motor neurons  in  neonatal  rats;  (b)  attenuate 
motor deficits in pmn/pmn and wobbler mice with neuromus- 
cular dysfunction; and (c) exert myotrophic effects by atten- 
uating morphological and functional changes associated with 
denervation  of rat  skeletal  muscle  (30-33).  In  the  intact 
nerve, CNTF immunoreactivity is observed predominantly 
in the cytoplasm of myelin-associated Schwann cells.  After 
injury, significant quantities  of CNTF protein are extracel- 
lularly released from the Schwann cells,  predominantly at a 
distal  area  from  the  lesion  (34-37).  Thus,  it  seems  that 
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Figure 5.  Accelerated  regeneration of  the transected 
hypoglossal nerve by constitutive expression of IL-6 
and IL-6R. Fluorogold  staining of  the hypoglossal  nu- 
clei of the non-TG control (A) and TG mice ex- 
pressing both IL-6 and IL-6R (B) prepared 4 wk after 
axotomy  are  shown. (Right) Operated side; (left) 
sham-operated side. > 
f"  60 
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Figure  6. 
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Time after nerve cut (weeks) 
Time course of nerve regeneration after axotorny in control 
80 
and TG mice expressing IL-6 and/or IL-6R. In this assay, 6+6R+TG (n = 
18; closed circles), 6+6R-TG (n =  15; open squares), 6-6R+TG (n =  15; 
open triangles), and 6-6R-TG mice (n =  15; open circles) were used. Hypo- 
glossal nerves were transected and nerve regeneration was examined at the 
time points indicated. Each dot represents the average value from three in- 
dividual mice. Vertical bars, SD. 
CNTF acts as a lesion factor similarly as has been observed 
for IL-6 in the present  study.  However,  the  regulation  of 
the  protein  amount  of IL-6  before  and  after  injury  ap- 
peared  to  be  different  from  that  of CNTF;  IL-6 immu- 
noreactivity was not detectable in the intact nerve, but was 
elevated  only after injury due  to the  upregulated synthesis 
of the IL-6 protein that is likely to become available for the 
neurons being regenerated.  Thus,  CNTF  appears  to work 
immediately upon injury and IL-6 may follow CNTF after 
de  novo  synthesis.  Concerning  the  expression  of IL-6 in 
the peripheral  nerve, previous reports  (38, 39) have shown 
that the  IL-6 transcripts,  as detected by Northern blotting, 
were  upregulated  in  the  injured  sciatic  nerve  and  facial 
nerve tissues.  In these studies,  however, functional impor- 
tance  of the  IL-6 mRNA  elevation,  histological localiza- 
tion of the IL-6 protein,  and IL-6R upregulation have not 
been demonstrated. In our present study, immunoreactivity 
to IL-6 was upregulated in Schwann cells  at the lesion site 
as well as in the hypoglossal nerve cell bodies in the brain 
stem. In the latter, upregulation of the immunoreactivity to 
IL-6R was also obvious. 
A functional receptor complex for CNTF is composed of 
three different chains, i.e., CNTFR, LIFR, and gp130 (8-19, 
40).  The  CNTF  signal  is  transmitted  through  the  mem- 
brane via the LIFR/gpl30 heterodimer which is formed by 
binding of CNTF to CNTFR. In the previous study, we have 
shown that the simultaneous addition of IL-6 and slL-6R, 
which induces the gp130/gp130 homodimer, mimics CNTF 
(41). In the present study, however, the biological meaning 
of the simultaneous expression of IL-6 and IL-6R in nerve- 
injured  mice and  6+6R+TG  mice  does not seem to  be  a 
simple  mimicry of the  biological function  of CNTF,  but 
instead appears to be a contribution to nerve regeneration. 
This is because both IL-6 and IL-6R protein  are upregu- 
lated after nerve injury and, more importantly, anti-IL-6R 
Ab retards the regeneration of transected axons.  The func- 
tional  aspect  of nerve  regeneration  by  IL-6  signaling  re- 
mains to be tested. 
TG mice expressing human IL-6R alone (6-6R+TG) did 
not exhibit faster nerve recovery, because endogenously ex- 
pressed  mouse  IL-6 does  not bind  to human  IL-6R  (42). 
At  the  fifth  week  of the  experiment  (Fig.  6),  6+6R  TG 
mice expressing human IL-6 alone showed slightly higher 
regeneration, but the extent was still very much smaller than 
that in 6+6R+TG mice. All in all,  the 6+6R-TG  mice did 
not show significant acceleration in nerve recovery. Since hu- 
man IL-6 is capable of binding to human and mouse IL-6R 
(42),  this  phenomenon  could be  explained  if we were  to 
assume  that  the  amount  of mouse  IL-6  expressed  after 
nerve injury is already sufficient for that of mouse IL-6R. 
It might be worth noting the number of neurons in the 
hypoglossal  nucleus  in  the  brain  stem  of the  6+6R+TG 
mice.  We  counted the  number of Fluorogold-stained  cell 
bodies in the hypoglossal nucleus in the brain stem of non- 
operated TG mice that had been injected with Fluorogold 
into  the  tongue.  It was  not  significantly  increased  in  the 
6+6R+TG  mice  (on  average,  27.3  +  1.2/section  in  the 
6+6R+TG  and  25.0  +  2.8/section  in  6-6R-TG  mice). 
Since  we  have  not  determined  the  amount  of transgene- 
derived human IL-6 and human IL-6R during embryogen- 
esis  and  early  postnatal  stages,  we  could  not  conclude 
whether  the  simultaneous  expression  of the  IL-6 and  IL- 
6R proteins  developmentally  affect the  number  of hypo- 
glossal neurons. 
gp130-stimulatory  cytokines  other  than  IL-6,  such  as 
LIF,  IL-I 1,  and oncostatin M,  deserve a thorough evalua- 
tion as additional potential neurotrophic molecules for the 
peripheral  nerve.  Indeed,  in vitro  and in vivo trophic  ef- 
fects of, for instance, LIF on motor neurons have been ob- 
served  (43).  The question as to whether individual gp 130- 
stimulator,/cytokines function redundantly or whether these 
factors act to perform distinct trophic actions in the periph- 
eral  nervous  system  still  remains  to  be  proved.  It will  be 
interesting to elucidate their physiological role during func- 
tional recovery of the neuron activities, their possible patho- 
physiological importance, and, as a consequence, their suit- 
ability for the treatment of nerve degenerative disease. 
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